Data-driven technologies and "big data" are changing numerous enterprises. Nonetheless, in numerous territories of research—including health and drug development—there is excessively little information accessible because of its delicate nature and the strict protection of individuals. At the point when data are scant, the conclusions and predictions made by researchers stay uncertain, and the coronavirus outbreak is one of these circumstances.
"When a person gets sick, of course, they want to get the best possible care. Then it would be important to have the best possible methods of personalized healthcare available," says Samuel Kaski, Academy Professor and the Director of the Finnish Center for Artificial Intelligence FCAI.
No comments:
Post a Comment